UBS Group’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $36.4M | Buy |
|
|||||
|
2022
Q2 | $12.8M | Buy |
|
|||||
|
2022
Q1 | $14.7M | Buy |
|
|||||
|
2021
Q4 | $48K | Buy |
|
|||||
|
2021
Q3 | $37K | Sell |
|
|||||
|
2021
Q2 | $905K | Buy |
|
|||||
|
2021
Q1 | $123K | Buy |
|
|||||
|
2020
Q4 | $63K | Sell |
|
|||||
|
2020
Q3 | $140K | Buy |
|
|||||
|
2020
Q2 | $111K | Sell |
|
|||||
|
2020
Q1 | $5.45M | Sell |
|
|||||
|
2019
Q4 | $11.5M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $30K | Sell |
|
|||||
|
2019
Q1 | $84K | Sell |
|
|||||
|
2018
Q4 | $126K | Sell |
|
|||||
|
2018
Q3 | $502K | Sell |
|
|||||
|
2018
Q2 | $2.5M | Buy |
|
|||||
|
2018
Q1 | $511K | Buy |
|
|||||
|
2017
Q4 | $232K | Sell |
|
|||||
|
2017
Q3 | $1.94M | Buy |
|
|||||
|
2017
Q2 | $76K | Sell |
|
|||||
|
2017
Q1 | $114K | Sell |
|
|||||
|
2016
Q4 | $97K | Buy |
|
|||||
|
2016
Q3 | $78K | Buy |
|
|||||
|
2016
Q2 | $14K | Buy |
|
|||||
|
2016
Q1 | $4K | Sell |
|
|||||
|
2015
Q4 | $25K | Buy |
|
|||||
|
2015
Q3 | $14K | Sell |
|
|||||
|
2015
Q2 | $85K | Buy |
|
|||||
|
2015
Q1 | $25K | Sell |
|
|||||
|
2014
Q4 | $76K | Buy |
|